Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cellid

Cellid
2006 FOUNDED
PRIVATE STATUS
Later Stage VC LATEST DEAL TYPE
5 INVESTORS
Description

Developer of immunotherapeutic vaccines designed to used patients' own cells for vaccination. The company's immunotherapeutic vaccines are personalized B cell-based vaccines to overcome the medical and technical limitations of current cancer and/or infectious disease therapy.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 1 Gwanak-ro, Gwanak-gu
  • Seoul National University, Building 142, Suite 504
  • Seoul
  • South Korea

+82 00-0000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cellid’s full profile, request a free trial.

Cellid Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 01-Jan-2016 Completed Clinical Trials - Phase 1
1. Grant 00.000 Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

Cellid Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
DSC Investment Venture Capital Minority 000 0000 000000 0
KTB Network Corporation Minority 000 0000 000000 0
STIC Investments PE/Buyout Minority 000 0000 000000 0
Green Cross Cell Corporation 000 0000 000000 0
Korea Health Industry Development Institute Corporation 000 0000 000000 0

Cellid Executive Team (1)

Name Title Board
Seat
Contact
Info
Kang Chang-il Ph.D Chief Executive Officer